432 related articles for article (PubMed ID: 25787829)
1. Stage III pancreatic cancer and the role of irreversible electroporation.
Al Efishat M; Wolfgang CL; Weiss MJ
BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
[TBL] [Abstract][Full Text] [Related]
2. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
4. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma.
Martin RC
J Gastrointest Surg; 2013 Oct; 17(10):1850-6. PubMed ID: 23929188
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
Martin RC; McFarland K; Ellis S; Velanovich V
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.
Martin RC; Durham AN; Besselink MG; Iannitti D; Weiss MJ; Wolfgang CL; Huang KW
J Surg Oncol; 2016 Dec; 114(7):865-871. PubMed ID: 27546233
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
9. Irreversible Electroporation for Locally Advanced Pancreatic Cancer: Where Do We Stand in 2017?
Tasu JP; Vesselle G; Herpe G; Richer JP; Boucecbi S; Vélasco S; Debeane B; Carretier M; Tougeron D
Pancreas; 2017 Mar; 46(3):283-287. PubMed ID: 28187107
[TBL] [Abstract][Full Text] [Related]
10. A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma.
O'Neill C; Hayat T; Hamm J; Healey M; Zheng Q; Li Y; Martin RCG
Surgery; 2020 Oct; 168(4):610-616. PubMed ID: 32631655
[TBL] [Abstract][Full Text] [Related]
11. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report.
Bagla S; Papadouris D
J Vasc Interv Radiol; 2012 Jan; 23(1):142-5. PubMed ID: 22221480
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation for locally advanced pancreatic cancer.
Tasu JP; Vesselle G; Herpe G; Richer JP; Boucebci S; Vélasco S; Carretier M; Debeane B; Tougeron D
Diagn Interv Imaging; 2016 Dec; 97(12):1297-1304. PubMed ID: 27856215
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
[TBL] [Abstract][Full Text] [Related]
15. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
[TBL] [Abstract][Full Text] [Related]
16. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
de Liguori Carino N; O'Reilly DA; Siriwardena AK; Valle JW; Radhakrishna G; Pihlak R; McNamara MG
Eur J Surg Oncol; 2018 Oct; 44(10):1486-1493. PubMed ID: 30146253
[TBL] [Abstract][Full Text] [Related]
17. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy in operable pancreatic cancer.
Wente MN; Büchler P; Friess H; Büchler MW
Swiss Surg; 2002; 8(2):74-80. PubMed ID: 12013694
[TBL] [Abstract][Full Text] [Related]
19. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.
Paiella S; Salvia R; Girelli R; Frigerio I; Giardino A; D'Onofrio M; De Marchi G; Bassi C
Updates Surg; 2016 Sep; 68(3):307-311. PubMed ID: 27535401
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol.
Venkat S; Hosein PJ; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):153-8. PubMed ID: 26365545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
